{
  "disease_name": "Hodgkin lymphoma",
  "synonyms": [
    "Hodgkin disease",
    "HL"
  ],
  "summary": "Hodgkin lymphoma is a cancer that develops in the lymph system, which is part of the immune system. It starts in different types of white blood cells called lymphocytes. A hallmark of Hodgkin lymphoma is the presence of multinucleated Reed–Sternberg cells in the lymph nodes.",
  "causes": [
    "Unknown",
    "Epstein-Barr virus (EBV) infection"
  ],
  "risk_factors": [
    "Age (early adulthood 20-39, late adulthood 65+)",
    "Male sex",
    "Past Epstein-Barr virus (EBV) infection",
    "Family history of Hodgkin lymphoma",
    "HIV/AIDS"
  ],
  "symptoms": [
    "Painless, swollen lymph nodes (neck, underarm, groin)",
    "Fever",
    "Drenching night sweats",
    "Unexplained weight loss",
    "Itchy skin",
    "Fatigue",
    "Splenomegaly (enlargement of the spleen)",
    "Hepatomegaly (enlargement of the liver)",
    "Pain following alcohol consumption",
    "Back pain",
    "Cyclical fever (Pel–Ebstein fever)"
  ],
  "diagnosis": [
    "Medical history and symptom assessment",
    "Physical examination",
    "Complete blood count (CBC)",
    "Blood chemistry studies",
    "Lactate dehydrogenase (LDH) test",
    "Erythrocyte sedimentation rate (ESR) test",
    "Blood tests to rule out other conditions",
    "Imaging tests (CT, PET, MRI)",
    "Lymph node biopsy",
    "Confirmation of cancer presence",
    "Identification of Reed–Sternberg cells in lymph node biopsies"
  ],
  "treatments": [
    "Chemotherapy",
    "Radiation therapy",
    "Targeted therapy",
    "Cancer immunotherapy",
    "Stem-cell transplantation",
    "Rituximab (for nodular lymphocyte-predominant subtype)",
    "Brentuximab vedotin",
    "Nivolumab",
    "Pembrolizumab"
  ],
  "related_genes": [],
  "subtypes": [
    "Classic Hodgkin lymphoma",
    "Nodular lymphocyte-predominant Hodgkin lymphoma",
    "Nodular sclerosis",
    "Lymphocyte depleted",
    "Mixed cellularity",
    "Lymphocyte-rich"
  ]
}